In early heart development, platelet-derived growth factor (PDGF) receptor expression in the heart ventricles is restricted to the epicardium. Previously, we showed that PDGFR␤ is required for coronary vascular smooth muscle cell (cVSMC) development, but a role for PDGFR␣ has not been identified. Therefore, we investigated the combined and independent roles of these receptors in epicardial development.
C ardiac disease is the leading cause of death in the industrial world. Although recent stem cell therapies have attempted to regenerate myocardium, there are still many physiological barriers to overcome, including fibrosis, inflammation, and insufficient blood vessel generation. Induction of cardiomyocyte regeneration is one proposed way to improve cardiac function, but it is clear that the noncardiomyocyte populations in the heart also contribute to the repair process. Noncardiomyocyte lineages (endothelial cells, vascular smooth muscle cells, and cardiac fibroblasts) are essential for blood vessel formation and matrix organization, and an understanding of the developmental signals that shape these cells may provide insights into disease pathogenesis and better heart injury therapies.
Coronary vascular smooth muscle cells (cVSMC) and cardiac fibroblasts develop from the epicardium in a multistep process involving cell proliferation, epithelial-tomesenchymal transition (EMT), and mesenchymal cell fate specification. 1 Several proteins have been implicated in the development of cVSMC from the epicardium, 2 but less is known about the epicardial-derived cardiac fibroblast population. It is proposed that cardiac fibroblasts are essential for normal cardiac function, and their role in matrix deposition during cardiac injury is well established. Yet, signaling pathways regulating their development are poorly understood.
Platelet-derived growth factor (PDGF) receptor tyrosine kinases are important for embryonic development and play essential roles in the forming vasculature. 3 Previously, we identified a role for PDGFR␤ as an important factor regulating epicardial-derived cVSMC development. 4 We and others observed PDGFR␣ in the epicardium 5, 6 ; however, no data exist regarding the fate of epicardial-derived cells (EPDCs) when PDGFR␣ is disrupted. The receptors are coexpressed in the epicardium until E13.5, but after this time point, receptor expression becomes mutually exclusive. These initial findings led us to investigate the role of PDGFR␣ individually and combined with PDGFR␤ during EPDC formation.
Using Cre/loxP recombination, we generated animals that lacked PDGFR␣, PDGFR␤, or both PDGF receptors in the epicardium. Epicardial deletion of both PDGF receptors resulted in failure of epicardial EMT and EPDC formation. Loss of PDGF signaling led to reduced Sox9 expression, and when Sox9 expression was restored in mutant hearts, the EMT defect was rescued. Interestingly, mutants lacking only one of the PDGF receptor genes exhibited a lineage specific requirement for each individual receptor. Loss of PDGFR␣ resulted in a deficit in cardiac fibroblast formation, whereas cVSMC development was unperturbed. Conversely, PDGFR␤ was required for cVSMC development 4 but not cardiac fibroblast development. Combined, our data demonstrate a novel role for PDGF receptors in epicardial EMT and EPDC development.
Methods
Additional methods are available in the Online Data Supplement at http://circres.ahajournals.org.
Mice were maintained on a mixed C57/Bl6ϫ129SV background. The strains in these experiments included PDGFR␣ GFP , 7 PDGFR␣ fl , 8 PDGFR␤ fl , 9,10 R26R YFP , 11 R26R tdT 12 (Jackson Labs), R26R LacZ , 13 WT1 iCre , 14 Tie2Cre Tg/0 , 15 and Gata5Cre Tg/0 . 16 All animal protocols and experiments were approved by the UTSW IACUC and conformed to National Institutes of Health guidelines for care and use of laboratory animals. Gata5Cre transgenic and WT1 iCre mice were kindly provided by Dr Pilar Ruiz-Lozano 4 (Burnham Institute) and Dr William Pu (Harvard University), respectively. WT1 iCre/ϩ animals were induced with tamoxifen at indicated time points. Tamoxifen (MP Biomedicals, 156738) was dissolved in sunflower seed oil (Sigma, S5007) at 20 mg/mL. We administered 0.1 mg/g body weight of tamoxifen by oral gavage. Controls used in most experiments were Gata5Cre-negative littermates. Animals used for controls in fibroblast isolation(s) were PDGFR␣ fl/ϩ , PDGFR␤ fl/ϩ , R26R LacZ/ϩ , and Gata5Cre Tg/0 .
Results

Loss of Both PDGF Receptors Causes Defects in Epicardial Cell Migration
Both PDGF receptors, ␣ and ␤, are expressed by the epicardium, and loss of PDGFR␤ alone causes a reduction in cVSMC. 4 To investigate a combined role for PDGF receptor signaling, we deleted PDGF receptors from epicardial cells using mice expressing the Gata5Cre transgene. 16 PDGFR EKO (EKO, or epicardial knockout) hearts had regions of epicardial detachment and hemorrhaging ( Figure 1A ). The detachment progressed temporally from the dorsal to ventral heart surface but resolved by birth (data not shown). Despite this phenotype, the epicardium expressed multiple, established epicardial markers (Online Figure IA and IB). Because PDGF receptor signaling has been associated with proliferation and survival, 17 we examined the epicardium and EPDCs for BrdU incorporation and cleaved caspase-3 activation. PDGFR EKO mutant values were similar to those obtained in controls (Online Figure IC and ID), suggesting that loss of PDGF receptor signaling does not affect cellular proliferation or survival of epicardial cells in vivo. Because epicardial formation was unaffected in PDGFR EKO mutants, we next assayed hearts for epicardial cell entry into the myocardium. To trace epicardium lacking PDGF receptors, we induced Cre-mediated recombination in epicardial cells just prior to EMT (E12.5) using a tamoxifen-inducible WT1 iCre allele 14 and analyzed migration at E14.5. Using R26R YFP reporter activity to follow the epicardial cells, we observed a loss of EPDCs when PDGF receptors were absent ( Figure 1B and 1C ). Similar results were obtained when using markers of undifferentiated EPDCs, WT1 18, 19 or mesenchymal cells, vimentin. 20 Both markers showed a severe reduction in the region immediately underlying the epicardium in PDGFR EKO hearts (Online Figure II and data not shown). Note that vimentin is a broad mesenchymal marker that is also expressed by nonepicardial-derived coronary endothelial cells. 21 Additionally, in an ex vivo migration assay, 4 fewer cells exited the epicardium in PDGFR EKO mutant hearts even when stimulated with EMT-inducing growth factors, hTGF␤ 1 22 and bFGF 23 ( Figure 1D ).
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PDGF Receptor Signaling Is Required for Epicardial Cell EMT
We surmised that loss of epicardial cell migration was caused by a defect in epicardial EMT. We first examined PDGFR EKO embryonic hearts for expression of transcriptional inducers of EMT, Snail 24 , Slug 25 , and Sox9 26, 27 . Interestingly, even though epicardial genes-such as WT1 and Tbx18-were unchanged, we consistently observed a significant reduction in Snail, Slug, and Sox9 transcript levels ( Figure 2A ).
EMT involves a complex series of events including the loss of epithelial morphology and the acquisition of mesenchymal actin filaments. Therefore, we examined EMT induction in primary epicardial cultures using a cocktail of growth factors. We compared cell morphology by bright field imaging and immunostaining for adherens junctions and filamentous actin organization (␤catenin and phalloidin, respectively). While control cultures lost their epithelial characteristics (junctional ␤catenin) and gained mesenchymal cell morphology (cytoplasmic actin stress fibers), PDGFR EKO mutant cultures remained epithelial, illustrating a failure to initiate EMT ( Figure 2B , Online Figure IIIA ).
EMT is also associated with changes in gene expression. To evaluate additional EMT markers, we performed qPCR analysis. Initial experiments revealed that primary cultures undergo EMT, but many of the genes commonly used to assess EMT were not significantly altered in the stimulated epicardial cultures. For example, we observed no changes in E-cadherin, ZO-1, ␣SMA, and vimentin expression (data not shown). Therefore, to generate an EMT profile specific for primary epicardial cultures, we performed gene expression analysis on E12.5 cultures treated with vehicle or hTGF␤ 1 (10 ng/mL), PDGFBB (20 ng/mL), and bFGF (25 ng/mL), all 3 being growth factors known to stimulate EMT 28 (GEO Series GSE27181). From these data, we generated a list of candidate genes and verified a subset that correlated with a change from an epithelial to a mesenchymal phenotype. Two epithelial markers that were consistently downregulated on EMT induction were Krt14 29, 30 and BVES. 31 We also identified a group of mesenchymal genes that were induced on EMT induction. This list included Calponin, 22 Snail, 32 Sox9, 27 Cdh6, 33 Col7a1, 34 MMP10, 35 and OPG. 36 -38 Having established these gene sets, we then investigated their expression during the EMT response in mutant cultures. For every gene examined, we found that expression in the mutant cultures was significantly different from stimulated control cultures ( Figure 2C through 2E). Interestingly, vehicle-treated mutant cultures consistently exhibited increased levels of the epithelial gene, Krt14. These data suggest that a defect in the process of EMT was present in PDGFR EKO epicardial cells.
Expression of Sox9 in PDGFR EKO Cells Rescues the EMT Defect
To determine potential genes that mediate PDGF driven EMT, we screened for gene expression differences using microarray data sets from whole hearts and primary epicardial cultures (GEO Series GSE27181). Comparison of control and PDGFR EKO data demonstrated that transcripts of an SRY-related family member, Sox9, were decreased in mutant E12.5 and E13.5 hearts and in primary epicardial cultures (Figure 2A , data not shown).
The correlation of Sox9 transcript levels with PDGF signaling led us to investigate a role for Sox9 in PDGFdependent EMT. In primary epicardial cultures, PDGF stimulation resulted in increased Sox9 expression ( Figure 3A ). We next determined how Sox9-induced expression impacted these cultures. In the absence of stimulation, Sox9 overexpression had little effect on the cultures, regardless of the genotype. However, AdSox9-transduced cultures stimulated with hTGF␤ 1 and PDGFBB changed from an epithelial morphology to a mesenchymal morphology ( Figure 3B , Online Figure IIIB) . These data suggested that additional signaling pathways were required to initiate a Sox9-mediated EMT in our primary epicardial cell cultures, similar to what has been observed in neural crest cells, 27, 39 but that Sox9 expression could induce EMT even in PDGFR EKO epicardial cells.
To examine Sox9's role in epicardial EMT gene expression, we transduced cultures with AdSox9 ( Figure 3C through 3E). These cultures had reduced epithelial (BVES and Krt14) gene expression, but mesenchymal gene expression remained unchanged. However, similar to the morphological assay, AdSox9 transduced and stimulated (hTGF␤ 1 and PDGFBB) cultures had both decreased epithelial gene expression and increased mesenchymal gene expression regardless of genotype ( Figure 3C Circulation Research June 10, 2011
Because Sox9 expression has not been documented in the epicardium previously, we examined hearts for Sox9 protein. Sox9 was present in a subpopulation of epicardial cells at E13.5 ( Figure 4A ), and a day later, Sox9 ϩ cells were present in both the epicardium and subepicardial mesenchyme ( Figure 4A ). Using the WT1 iCre and R26R YFP alleles, we confirmed that Sox9 ϩ cells are epicardial derived (Online Figure IVA) . In contrast to controls, Sox9 expression in PDGFR EKO hearts was significantly reduced at E13.5 and virtually absent at E14.5 ( Figure 4A and 4B ). We observed a PDGF receptor gene dosage effect on Sox9-expressing cells that correlated with the number of functional PDGF receptor alleles present (Online Figure  IVB) . Individual PDGF receptor epicardial mutants also contained reduced numbers of Sox9 ϩ cells ( Figure 4B ), suggesting that signaling from either receptor is involved in Sox9 expression.
To determine whether Sox9 could rescue the PDGFR EKO epicardial migration defect, we transduced control and PDGFR EKO hearts with AdGFP and AdSox9 ( Figure 4C ). AdSox9 transduction was able to induce migration of epicardial cells from both control and PDGFR EKO hearts. This result suggested that, in whole-heart cultures, Sox9 was sufficient for inducing epicardial EMT but not in 
Loss of PDGFR␣ Leads to an EMT Defect in a Subpopulation of Epicardial Cells
Our data suggested that both PDGF receptors are required for EMT, but results from the PDGFR␤ epicardial deletion demonstrated a VSMC lineage defect in epicardial development. 4 Therefore, we decided to further investigate the individual role of the PDGF receptors during EPDC development. To obtain a more precise view on PDGF receptor expression overlap, we used flow cytometry. We observed that both receptors were initially coexpressed at early embryonic stages (E13.5) but became mutually exclusive at later stages (E16.5) (Online Figure V) . With a GFP knock-in allele 7 to follow cells expressing PDGFR␣, GFP expression appeared in most epicardial cells at E13.5 ( Figure 5A ). At E13.5, PDGFR␣ GFP/GFP mutant hearts exhibited epicardial blistering that was milder than PDG-FR EKO hearts (data not shown). However, this blistering was less severe than that observed in embryos null for a different PDGFR␣ allele. 40 The phenotypic differences described for the PDGFR␣ null embryos could be caused by differences in genetic background or by the fact that 2 of these studies (this report and one by Bax et al 41 ) excluded embryos that had retarded growth from analysis. With regard to the number of GFP ϩ cells in the epicardium, we observed no differences between control and mutant hearts ( Figure 5A ). However, at E17.5, GFP ϩ cells were present within the myocardium of heterozygote hearts, but no GFP-expressing cells were observed within the myocardium of PDGFR␣ GFP/GFP hearts. These data suggested that loss of PDGFR␣ signaling leads to a disruption of a cell population that might arise from the epicardium and is consistent with a recent report showing reduced WT1 ϩ cell migration in PDGFR␣ GFP/GFP hearts. 41 To determine whether the loss of PDGFR␣-expressing cells in the myocardium of the null was caused by a failure in PDGFR␣-dependent cell migration from the epicardium, we deleted PDGFR␣ in epicardial cells. PDGFR␣ GFP/EKO hearts showed a reduction of GFP expressing cells within the myocardium, similar to PDGFR␣ GFP/GFP animals ( Figure  5B ). Lineage tracing at E12.5 using an inducible, epicardialspecific Cre mouse line (WT1 iCre ) 14 and R26R tdT 12 demonstrated that GFP-expressing cells were epicardial derived. In addition, when PDGFR␣ epicardial function was disrupted, migration of PDGFR␣ GFP positive cells and EPDCs into the heart was reduced ( Figure 5C and 5D ).
PDGFR␣ Mutant Hearts Have a Selective Loss of Cardiac Fibroblasts
We next examined whether there was a defect in the formation of epicardial derivatives in the absence of PDGF receptor signaling. Because epicardial EMT was disrupted, we expected aberrant cVSMC and cardiac fibroblast development. Surprisingly, the expected Mendelian ratio of PDGFR␣ EKO , PDGFR␤ EKO , and PDGFR EKO mutant animals was recovered at weaning and up to 1 year after birth. No measurable defects in cardiac size or function were observed (Online Figure VI) . Loss of PDGFR␤ alone results in an absence of epicardial-derived cVSMC, but a secondary population of cVSMC is initially present at the aortic root, 4 which continues to expand as the animals age (data not shown). This rescue may explain why loss of epicardial cVSMC does not lead to lethality. Examination of the endothelial component of the coronary vasculature suggested that patterning of the vessels in the PDGFR EKO hearts was similar to that previously reported for the PDGFR␤ EKO , 4 and that endothelial cell presence within the heart was not disrupted by a lack of EPDCs. We determined the consequences of disrupted epicardial EMT by examining hearts for epicardial derivatives. Staining for cVSMC markers, SM22␣, smooth muscle myosin heavy chain (SMMHC), ␣-smooth muscle actin, and PDGFR␤ demonstrated that cVSMC content of PDGFR␣ EKO hearts was unaffected ( Figure 5E and data not shown) . Because the smooth muscle cell markers that we examined should detect VSMC as well as pericytes, we conclude that loss of PDGFR␣ does not affect the mural cell lineage. By contrast, PDGFR EKO hearts showed a reduction in all of these markers (data not shown), similar to the loss that we reported in PDGFR␤ mutant hearts. These data, in combination with the observed loss of GFP ϩ cells, suggested that PDGFR␣ might be required for the formation of an EPDC population distinct from VSMCs, cardiac fibroblasts.
To determine whether PDGFR␣ was required for cardiac fibroblast formation, we analyzed R26R YFP epicardial lineage tagged hearts for a cardiac fibroblast surface marker, Thy1. [42] [43] [44] Epicardial-derived fibroblasts were defined as YFP ϩ , Thy1 ϩ , and CD31 Ϫ ( Figure 6A ). Deletion of PDGFR␣ either individually or in combination with PDGFR␤ (PDGFR␣ EKO and PDGFR EKO , respectively) resulted in a loss of epicardial-derived cardiac fibroblasts and an absence of YFP ϩ cells in PDGFR EKO hearts. Epicardial-derived fibroblast numbers in hearts lacking PDGFR␤ (PDGFR␤ EKO ) were similar to controls ( Figure  6A ). Next, we generated primary cardiac fibroblast cultures and traced the epicardial lineage using Gata5Cre transgene and an R26R LacZ allele to identify EPDCs. 
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Primary cardiac fibroblasts isolated from PDGFR EKO and PDGFR␣ EKO hearts had a paucity of epicardial-derived cardiac fibroblasts (␤-galactosidase ϩ ). By contrast, the number of epicardial-derived cardiac fibroblasts observed in controls and PDGFR␤ EKO hearts were very similar ( Figure 6B and 6C) . Because a population of cells grew from PDGFR EKO and PDGFR␣ EKO primary fibroblast cultures, we surveyed hearts for overall fibroblast content by detecting transcripts of fibroblast enriched genes. The qPCR demonstrated, on average, a 50% reduction in fibroblast gene transcripts in PDG-FR EKO hearts ( Figure 7E ). We then used Col1a1 (Figure 7A and 7B) and prolyl-4-hyroxylase ␤ (P4hb) 45 (Figure 7C and 7D) to identify individual collagen-producing cells. To establish the optimal time point to quantify developing fibroblasts, we examined Col1a1 and PDGFR␣ expression perinatally. Cells expressing these 2 genes were evident from E18.5 to P7, but after P7, in situ detection of gene expression appeared to taper off (Online Figure VIIA) . These data suggested that matrix production by fibroblasts fell within a very discrete time window. A greater than 50% reduction was observed in the fibroblast population of PDGFR EKO at P7, and a reduction in these same fibroblast markers was observed in a PDGFR␣ epicardial mutant at E18.5 ( Figure  7A through 7D and Online Figure VIIB) . These calculations were an overestimation of remaining fibroblasts as the nonepicardial-derived VSMC surrounding the coronary vasculature, 4 the endocardium, and the epicardium also produced collagen ( Figure 7A ). To gain insights into the potential source of the cells in primary cardiac fibroblast cultures, we generated fibroblasts from Tie2Cre;R26R LacZ animals, in which all cells of endothelial origin should express ␤-galactosidase, and found that 21Ϯ7% (nϭ4 cultures) of the prolyl-4 hydroxylase or ␣SMA-expressing, adherent cells had an endothelial origin, as has been previously suggested. 46 To determine whether a reduction in fibroblasts resulted in any extracellular matrix (ECM) defects, we examined hearts for levels of periostin (Postn), an extracellular matrix molecule secreted by cardiac fibroblasts. 47 Periostin expression in PDGFR␣ EKO and PDGFR EKO hearts had a marked reduction, whereas the periostin level in PDGFR␤ EKO was unaffected ( Figure 7F ). We also investigated adult mice for generalized defects in matrix deposition. Focusing on perivascular regions, we used Masson Trichrome stain to identify collagen deposition from PDGFR␣ EKO , PDGFR␤ EKO , and PDGFR EKO hearts. Deletion of PDGFR␣ either individually or in combination with PDGFR␤ (PDGFR␣ EKO and PDGFR EKO , respectively) led to a reduction in collagen, while mice lacking PDGFR␤ (PDGFR␤ EKO ) in epicardial cells and their derivatives were similar to controls ( Figure 7G) .
These results suggested that cardiac fibroblast development is disrupted in PDGFR EKO and PDGFR␣ EKO hearts and that these epicardial-derived fibroblasts are required for matrix production in the developing heart. In conclusion, our data show a unique role for PDGF signaling in regulating epicardial EMT and fate specification of EPDCs.
Discussion
Since the discovery of the origin of cVSMC and cardiac fibroblasts Ͼ18 years ago, multiple signaling pathways have been identified that affect the formation, attachment, or EMT of the epicardium. However, few genes have been identified that are essential for cardiac fibroblast formation. Here, we have not only identified a unique requirement for PDGF receptor signaling in regulating epicardial EMT and EPDC formation, but also an essential role for PDGFR␣, specifically in cardiac fibroblast formation.
Several growth factor signaling pathways have been implicated in the induction of EMT during development and various pathological states, and PDGF has been linked to the EMT process during cancer progression, organ fibrosis, 48 -50 smooth muscle cell generation from the chicken proepicardium, 51 and in the regenerating zebrafish heart. 52 Some suggested mechanisms for PDGF's role in EMT include stabilization of ␤catenin 53 or induction of transcriptional activators of EMT, such as ZEB1/2 and Snai2. 54 However, we do not observe these specific effects in epicardial cells after PDGF stimulation. We have identified the transcription factor Sox9 as a downstream target of PDGF-stimulated EMT. Our data show that Sox9 could rescue the EMT defect seen in PDGF receptor mutants and that Sox9 expression was upregulated on PDGF stimulation of epicardial cells. These data are consistent with the known role for Sox9 in avian neural crest cell EMT. 27 Sox9 is a member of the SRY-related HMG-box family of transcription factors that is important for the development of many tissues and cell types. Cardiovascular defects have been reported in Sox9 mutants, 55, 56 but no epicardial phenotype has been described. Our data suggest that Sox9 could be an important component of PDGF receptor signaling during epicardial EMT, but further investigation is necessary to determine the mechanistic link between PDGF and Sox9.
Our data show that loss of both PDGF receptors led to defective EMT and failure to form any epicardial derivatives. Interestingly, individual deletion of the PDGF receptors also led to reduced epicardial EMT and a loss of only a subpopulation of EPDCs. There are 2 potential scenarios to explain when PDGF receptor function is required. In the first scenario, epicardial cells are heterogeneous, and each epicardial cell would only give rise to a specific lineage of 
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EPDCs, either VSMC or fibroblast. Here, PDGF signaling might regulate a lineage-specific EMT. Consistent with this possibility, experiments using limiting amounts of retrovirus to transduce the proepicardial organ 57 revealed that tagged cells contributed only to the VSMC lineage. However, there have been no reports suggesting differential gene expression in the epicardium. For example, Tbx18, Tcf21, Raldh2, and both of the PDGF receptors seem to be uniformly expressed in the epicardium before EMT. A second possibility for PDGF function is that PDGF signaling by each receptor is redundant with regard to the EMT process, but after EMT, PDGFR␣ is expressed in fibroblast progenitors, and PDGFR␤ is in cVSMC. In this scenario, the most likely role for PDGF receptor signal transduction is expansion and migration of the progenitor population. 17, 58 These unanswered questions require further investigation using temporal deletion to identify the window of epicardial fate specification. The role of cardiac fibroblasts in heart pathogenesis is well appreciated, but the function of these cells during development is poorly understood. It has been proposed that cardiac fibroblasts perform a variety of essential duties during heart formation. These include stimulation of cardiomyocyte proliferation, 43 isolation of the ventricular from the atrial conduction system, 59 distribution of mechanical forces, 60 and of course, deposition and degradation of ECM. Recent estimates are that cardiac fibroblasts comprise about 27% of the cells within the murine heart, 61 but our data demonstrate that these cells are dispensable for heart development. Under nonpathological conditions, mice without epicardial derived fibroblasts lack adventitial collagen, but heart function is normal.
Because many cell populations have been proposed to contribute to fibrosis formation during pathological circumstances, there is the possibility that another source of fibroblasts fills the void. Proposed origins for this substitute fibroblast population include endothelial cells, fibrocytes, monocytes, and mural cells. 60 A complete functional substitution by these cells in the absence of epicardialderived fibroblasts is unlikely because mutant hearts that were 8 to 10 weeks old continued to lack adventitial ECM. Comparison of PDGFR␣ EKO with PDGFR EKO hearts did suggest a partial rescue of the ECM, presumably by the existing cVSMC, although the levels of matrix never appear to reach wild-type levels. While our initial examination suggests no major deficits in mutant animals, further studies are warranted to investigate cardiac homeostasis and other functional parameters such as conduction and stress response.
In summary, we demonstrate that cardiac fibroblast and cVSMC development is mediated by a combined role of the PDGF receptors in controlling epicardial EMT. This process appears to be linked to a lineage-specific requirement of the receptors. Specifically, PDGFR␣ is essential for cardiac fibroblast development. Finally, we establish a novel role for Sox9 as a critical downstream component of PDGF signaling in regulating epicardial EMT.
